Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.630
+0.010 (0.28%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $38.72 million as of April 25, 2025. Its market cap has decreased by -53.43% in one year.
Market Cap
38.72M
Enterprise Value
14.95M
1-Year Change
-53.43%
Ranking
Category
Stock Price
$3.63
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $38.72M, an increase of 27.66%. That is a compound annual growth rate of 5.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 38.72M | 12.54% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |